top of page

Публикации

2019 год

​

 

  1. Baykov S., Tarasenko M., Zelenkov L. E., Kasatkina S., Savko P., Shetnev A. Diastereoselective Opening of Bridged Anhydrides by Amidoximes Providing Access to 1,2,4-Oxadiazole/Norborna(e)ne Hybrids. Eur. J. Org. Chem., 2019, 5685–5693. (IF 3.029) 

  2. Shetnev A., Shlenev R., Efimova J., Ivanovskii S., Tarasov A., Petzer A., Petzer J. P. 1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B. Bioorganic & medicinal chemistry letters, 2019, 29(21), 126677. (IF 2.44) 

  3. Filimonov S.I., Chirkova Z.V., Kabanova M.V., Makarova E.S., Shetnev A.A., Panova V.A. A Condensation of Biginelli products with 1,3-benzenediols: a facile access to diastereomerically pure hexahydro-5H-chromeno[4,3-d]pyrimidin-5-ones. Chemistry Select, 2019, 4 (33), 9550-9555. (IF 1.716) 

  4. Михердов А. С., Байков С. В., Проскурина И. К., Шетнев А. Котов А.Д. Получение и свойства C,N-хелатных карбеновых комплексов палладия(II) c 2-аминобензо[d]тиазольным фрагментом. Журнал общей химии, 2019, 89, 10, 1572-1579. (IF 0.675) 

  5. Panova V.A., Korsakov M.K., Shetnev A.A., Filimonov S.I. Synthesis of Substituted 5-hydroxypyrazolo[1,5-a]quinoxalin-4-ones. Mendeleev Communications, 2019, 29 (1), 114-115. (IF 2.01)

  6. Shetnev A., Baykov S., Kalinin S., Belova A.,Sharoyko V., Rozhkov A., Zelenkov L., Tarasenko M., Sadykov E., Korsakov M., Krasavin M. 1,2,4-Oxadiazole/2-Imidazoline Hybrids: Multi-target-directed Compounds for the Treatment of Infectious Diseases and Cancer. International Journal of Molecular Sciences, 2019, 20(7), 1699. (IF 4.10)

  7. Bolotin D.S., Korzhikov-Vlakh V., Sinitsyna E., Yunusova S. N., Suslonov V. V., Shetnev A., Kukushkin V.Y. Biocompatible zinc(II) 8-(dihydroimidazolyl)quinoline complex and its catalytic application for synthesis of poly(L,L-lactide). Journal of Catalysis, 2019, 372, 362–369. (IF 6.759)

  8. Krasavin M., Shetnev A., Baykov S., Kalinin, S., Nocentini, A., Sharoyko, V., Poli, G., Tuccinardi, T., Korsakov, M., Tennikova, T. B., Supuran, C. T. Pyridazinone-substituted benzenesulfonamides display potent inhibition of membrane-bound human carbonic anhydrase IX and promising antiproliferative activity against cancer cell lines. Eur. J. Med. Chem., 2019, 168, 301-314. (IF 4.82) 

  9. Krasavin, M., Shetnev A., Sharonova T., Baykov S., Kalinin S., Nocentini A., Sharoyko V., Poli G., Tuccinardi T., Presnukhina S., Tennikova T. B., Supuran C. T. Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment. Eur. J. Med. Chem., 2019, 164, 92-105. (IF 4.82) 

  10. Shetnev A., Osipyan A., Baykov S., Sapegin A., Chirkova Z., Korsakov M., Petzer A., Engelbrecht I. and Petzer J. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework. Bioorganic & Medicinal Chemistry Letters, 2019, 29(1), 40-46. (IF 2.44)

2018 год

​

​

  1. Tarasenko M., Sidneva V., Belova A., Romanycheva A., Sharonova T., Baykov S, Shetnev A, Kuznetsov M. An efficient synthesis and antimicrobial evaluation of 5-alkenyl- and 5-styryl-1,2,4-oxadiazoles. Arkivoc, 2018, (7), 458–470. (IF 1.2)

  2. Sharonova T., Pankrat’eva V., Savko P., Baykov S., Shetnev A. Facile room-temperature assembly of the 1,2,4-oxadiazole core from readily available amidoximes and carboxylic acids. Tetrahedron Letters, 2018, 59(29), 2824–2827. (IF 2.113) 

  3. Krasavin M., Shetnev A., Sharonova T., Baykov S., Tuccinardi T., Kalinin S, Angeli A., Supuran C. T. Heterocyclic periphery in the design of carbonic anhydrase inhibitors: 1,2,4-Oxadiazol-5-yl benzenesulfonamides as potent and selective inhibitors of cytosolic h CA II and membrane-bound h CA IX isoforms. Bioorganic Chemistry, 2018, 76, 88–97. (IF 3.96) 

2017 год

​

​

  1. Tarasenko M., Duderin N., Sharonova T., Baykov S., Shetnev A., Smirnov, A.V. (2017). Room-temperature synthesis of pharmaceutically important carboxylic acids bearing the 1,2,4-oxadiazole moiety. Tetrahedron Lett., 2017, 58(37), 3672–3677. (IF 2.113) 

  2. Shetnev A.A., Zubkov, F.I. The latest advances in chemistry of 1,2,4-oxadiazines (microreview). Chemistry of Heterocyclic Compounds, 2017, 53(5), 495–497. (IF 1.201) 

  3. Baykov S., Sharonova T., Shetnev A., Rozhkov S., Kalinin S., Smirnov A. The first one-pot ambient-temperature synthesis of 1,2,4-oxadiazoles from amidoximes and carboxylic acid esters.Tetrahedron, 2017, 73, 945-951. (IF 2.33) 

  4. Krasavin M., Korsakov M., Zvonaryova Z., Semyonychev E., Tuccinardi T., Kalinin S., Tanç M., Supuran C. T. Human carbonic anhydrase inhibitory profile of mono- and bis-sulfonamides synthesized via a direct sulfochlorination of 3-and 4-(hetero)arylisoxazol-5-amine scaffolds. Bioorg. Med. Chem., 2017, 25, 1914-1925. (IF 3.42)

  5. Ferraroni M., Luccarini L., Masini E., Korsakov M., Scozzafava A., Supuran C. T., Krasavin M. 1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: potency is supported by X-ray crystallography of two leads. Bioorg. Med. Chem., 2017, 25, 4560-4565. (IF 3.42)

  6. Krasavin M., Korsakov M., Ronzhina O., Tuccinardi T., Kalinin S., Tanç M., Supuran C.T. Primary mono- and bis-sulfonamides obtained via regiospecific sulfochlorination of N-arylpyrazoles: inhibition profile against a panel of human carbonic anhydrases. J. Enz. Inhib. Med. Chem., 2017, 32, 920-934. (IF 2.32)

Логотип с прозрачным фоном.png

Мы создаем технологии для Вас

Email: m.korsakov@yspu.org

Телефон: +7 (910) 662-76-26

150010, г. Ярославль, ул. Технопарковая 11/2

  • White Facebook Icon

© 2020-2021 Центр трансфера фармацевтических технологий им. М.В. Дорогова

bottom of page